Novoprotein Scientific Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Novoprotein Scientific has a total shareholder equity of CN¥2.1B and total debt of CN¥18.1M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥2.2B and CN¥108.8M respectively.
Belangrijke informatie
0.8%
Verhouding schuld/eigen vermogen
CN¥18.11m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥668.95m |
| Aandelen | CN¥2.13b |
| Totaal verplichtingen | CN¥108.78m |
| Totaal activa | CN¥2.24b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 688137's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥54.6M).
Langlopende schulden: 688137's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥54.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 688137 has more cash than its total debt.
Schuld verminderen: 688137 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Schuldendekking: 688137's debt is well covered by operating cash flow (205.7%).
Rentedekking: Insufficient data to determine if 688137's interest payments on its debt are well covered by EBIT.